Publikace
- In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase2024 | Lékařská fakulta v Hradci Králové
- Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer2021 | Publikace bez příslušnosti k fakultě
- Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy2020 | Lékařská fakulta v Hradci Králové
- Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity2019 | Lékařská fakulta v Hradci Králové
- Purin-6-one and pyrrolo[2,3-d]pyrimidin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity2018 | Lékařská fakulta v Hradci Králové
- Novel caffeine derivatives with antiproliferative activity2016 | Lékařská fakulta v Hradci Králové
- Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy2016 | Publikace bez příslušnosti k fakultě
- Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring2015 | Publikace bez příslušnosti k fakultě
- Tacrine-Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity2015 | Publikace bez příslušnosti k fakultě
- 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment2015 | Publikace bez příslušnosti k fakultě
Loading network view...